These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 17204725)

  • 1. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma.
    Lazarus SC; Chinchilli VM; Rollings NJ; Boushey HA; Cherniack R; Craig TJ; Deykin A; DiMango E; Fish JE; Ford JG; Israel E; Kiley J; Kraft M; Lemanske RF; Leone FT; Martin RJ; Pesola GR; Peters SP; Sorkness CA; Szefler SJ; Wechsler ME; Fahy JV;
    Am J Respir Crit Care Med; 2007 Apr; 175(8):783-90. PubMed ID: 17204725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
    Robinson DS; Campbell D; Barnes PJ
    Lancet; 2001 Jun; 357(9273):2007-11. PubMed ID: 11438132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.
    Williams B; Noonan G; Reiss TF; Knorr B; Guerra J; White R; Matz J
    Clin Exp Allergy; 2001 Jun; 31(6):845-54. PubMed ID: 11422148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.
    Laviolette M; Malmstrom K; Lu S; Chervinsky P; Pujet JC; Peszek I; Zhang J; Reiss TF
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1862-8. PubMed ID: 10588598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma.
    Jayaram L; Duong M; Pizzichini MM; Pizzichini E; Kamada D; Efthimiadis A; Hargreave FE
    Eur Respir J; 2005 Jan; 25(1):41-6. PubMed ID: 15640321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma.
    American Lung Association Asthma Clinical Research Centers
    Am J Respir Crit Care Med; 2007 Feb; 175(3):235-42. PubMed ID: 16998094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
    Malmstrom K; Rodriguez-Gomez G; Guerra J; Villaran C; Piñeiro A; Wei LX; Seidenberg BC; Reiss TF
    Ann Intern Med; 1999 Mar; 130(6):487-95. PubMed ID: 10075616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients.
    Tohda Y; Fujimura M; Taniguchi H; Takagi K; Igarashi T; Yasuhara H; Takahashi K; Nakajima S
    Clin Exp Allergy; 2002 Aug; 32(8):1180-6. PubMed ID: 12190656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
    Lu S; Liu N; Dass SB; Reiss TF
    J Asthma; 2009 Jun; 46(5):465-9. PubMed ID: 19544166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
    Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Add-on montelukast to inhaled corticosteroids protects against excessive airway narrowing.
    Ulrik CS; Diamant Z
    Clin Exp Allergy; 2010 Apr; 40(4):576-81. PubMed ID: 20128823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M; Cerruti JL; Delannay B; Hérent M; Spilthooren F; Desfougères JL
    Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma.
    Deykin A; Wechsler ME; Boushey HA; Chinchilli VM; Kunselman SJ; Craig TJ; DiMango E; Fahy JV; Kraft M; Leone F; Lazarus SC; Lemanske RF; Martin RJ; Pesola GR; Peters SP; Sorkness CA; Szefler SJ; Israel E;
    Am J Respir Crit Care Med; 2007 Feb; 175(3):228-34. PubMed ID: 16973987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of montelukast and beclomethasone on airway function and asthma control.
    Israel E; Chervinsky PS; Friedman B; Van Bavel J; Skalky CS; Ghannam AF; Bird SR; Edelman JM
    J Allergy Clin Immunol; 2002 Dec; 110(6):847-54. PubMed ID: 12464949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast.
    Kraft M; Cairns CB; Ellison MC; Pak J; Irvin C; Wenzel S
    Chest; 2006 Dec; 130(6):1726-32. PubMed ID: 17166989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.
    Muijsers RB; Noble S
    Paediatr Drugs; 2002; 4(2):123-39. PubMed ID: 11888359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients.
    Löfdahl CG; Reiss TF; Leff JA; Israel E; Noonan MJ; Finn AF; Seidenberg BC; Capizzi T; Kundu S; Godard P
    BMJ; 1999 Jul; 319(7202):87-90. PubMed ID: 10398629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.